Related Experiment Videos
Oxytocin during myomectomy: a randomized study
Aubert Agostini1, Isabelle Ronda, Fabrice Franchi
1Service de Gynécologie, Hôpital La Conception, 147 Boulevard Baille, 13385 Marseille, France. aagostini@mail.ap-hm.fr
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|January 18, 2005
Summary
Oxytocin administration during myomectomy did not significantly reduce peroperative blood loss or transfusion rates in a randomized study. The benefits of using oxytocin to prevent surgical hemorrhage appear limited.
Area of Science:
- Obstetrics and Gynecology
- Surgical Hemorrhage Management
- Pharmacological Interventions
Background:
- Myomectomy is a common surgical procedure to remove uterine fibroids.
- Peroperative blood loss and the need for transfusions are significant concerns during myomectomy.
- Oxytocin is a uterotonic agent with potential hemostatic properties.
Purpose of the Study:
- To investigate the efficacy of oxytocin in minimizing peroperative blood loss during myomectomy.
- To assess the impact of oxytocin on blood transfusion and autotransfusion rates in myomectomy patients.
Main Methods:
- A randomized, double-blind, placebo-controlled study involving 94 patients undergoing myomectomy.
- Patients were assigned to receive either oxytocin or a placebo during the surgical procedure.
- Primary outcome measures included peroperative blood loss, blood transfusion, and autotransfusion rates.
Main Results:
- No statistically significant difference in peroperative blood loss was observed between the oxytocin group (508 +/- 558 ml) and the placebo group (451 +/- 336 ml; P=0.55).
- Rates of autotransfusion and blood transfusion were comparable between the two study groups.
- The study found no demonstrable benefit of intraoperative oxytocin in reducing blood loss during myomectomy.
Conclusions:
- Intraoperative oxytocin administration does not effectively reduce peroperative blood loss during myomectomy.
- The routine use of oxytocin to prevent hemorrhage in this surgical context is not supported by the study findings.
- Further research may be needed to explore alternative or adjunct strategies for hemorrhage control in myomectomy.